Skip to main content

EasyCOV : saliva test for Covid-19

Sensitivity: 86% – Specificity: 99% validated by a clinical study, same performance on the new variants

EasyVID, the EasyCOV PCR assay implementation device, has been specifically designed and adapted to accurately heat the tubes containing the different reagents.

Characteristics :

  • Nomadic IVD medical device  

  • CE certified

  • Dedicated to the EasyCOV test protocol

Unit Price (escl. vat)


Number of wells :
Independence of well control :
Manual protocol programming :
Indicator light for test result usability :
Heating up time :
20 min


Source sector :
220V 50Hz / 110V 60Hz
Power supply cable :
Battery backup :


Operating temperature :
5 °C min / 40 °C max
20% min / 80% max
Dimensions :
300 × 270 × 85 mm (L × W × H)
2.5 kg

EasyCOV: Rapid and reliable salivary screening test for Covid-19

Tame-Care, SkillCell and Alcediag (Sys2Diag / CNRS), and VOGO have pooled their expertise in chemistry, electronics and digital applications to develop a global saliva screening solution called EasyCOV®.


Test kit

35 tests ready to use


Heating device

Ergonomic and nomadic

Application VOGO


Free and SI-DEP compatible

This test dedicated to the fight against the Covid-19 pandemic is based on the analysis of saliva. Co-developed with the CNRS, EasyCOV allows, as indicated by several first-rate scientific studies, an efficient detection of Covid-19, a non-invasive sampling and a safe implementation.
The performance of EasyCOV has notably been validated by a study carried out at Montpellier University Hospital.

Download scientific results

Press release-30 November 2020


Advantages EasyCOV

  • RELIABLE - 86% sensitivity and 99% specificity, including on the variants detected to date.
  • COMFORTABLE AND PAINLESS- A simple saliva sample
  • FIELD - Its ready-to-use consumables and its implementation device (EasyVID) that can be transported to the operational environment make it possible to deploy this solution outside the laboratory.
  • FAST - A test result in 40 min.
  • SIMPLE - Simple visual interpretation through colour recognition.

This saliva test, marketed internationally from June 2020, was approved in France by the HAS in December 2020 and is now reimbursable since January 2021.
This reliable, painless, rapid and easily deployable screening allows mass testing and optimisation of containment and decontainment strategies.

Test procedure


The EasyCOV test and its EasyVID® implementation device, offers the ability to easily deploy Covid-19 test points in different locations:

  • Airports
  • Ports
  • Stations
  • Establishments opening to the public
  • Companies, 
  • Concert halls
  • Sports clubs
  • ...

EasyVID Flow, a solution for large test flows

In the context of deployments in these different locations, flow management can be essential in airports, guys, concert halls, that's why we have developed a solution called EasyVID Flow including :

  • All the necessary equipment to carry out 100 tests in 1h30 (EasyCOV test, EasyVID machine, and EasyCOV Reader application)
  • All the documentation relating to the implementation of the test lines
  • Two days of on-site training

As an example, it enables an A320 (about 200 people) to be tested in an airport context in 1 hour. 
This solution can be implemented in a variety of contexts (airports, theatres, trade shows, etc.) requiring mass tests to be carried out over a limited period of time


If you are interested in ordering or distributing these solutions, please contact Tame-Care with your request and provide us with the necessary information to contact you.


Contact Tame-Care

by e-mail

Become a Tame-Care distributor!

Are you interested in our products and would you like to distribute them?

Become a distributor!


To learn more about:

  • the EasyCOV saliva test
  • the EasyVID heating machine
  • the EasyCOV-Reader application

FAQ Page

Other products

26 rue du Bocage
85660 Saint-Philbert-de-Bouaine

Follow Tame-Care

Subscribe to the newsletter

Stay informed on Tame-Care news by subscribing to the newsletter